Page last updated: 2024-08-17
isatin and Cancer of Ovary
isatin has been researched along with Cancer of Ovary in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Anand, A; Chowdhary, S; Kaur, S; Kumar, V; Raza, A; Sharma, AK | 1 |
Abdalla, AN; Al-Salem, HS; Albalawi, FS; Alkahtani, HM; Alqathama, A; Arifuzzaman, M; Issa, IS; Rahman, AFMM | 1 |
Other Studies
2 other study(ies) available for isatin and Cancer of Ovary
Article | Year |
---|---|
Isatin-indoloquinoxaline click adducts with a potential to overcome platinum-based drug-resistance in ovarian cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; DNA; Female; Humans; Intercalating Agents; Isatin; Ovarian Neoplasms; Structure-Activity Relationship | 2024 |
A Series of Isatin-Hydrazones with Cytotoxic Activity and CDK2 Kinase Inhibitory Activity: A Potential Type II ATP Competitive Inhibitor.
Topics: Breast Neoplasms; Cyclin-Dependent Kinase 2; Cytotoxins; Female; Humans; Hydrazones; Isatin; MCF-7 Cells; Molecular Docking Simulation; Neoplasm Proteins; Ovarian Neoplasms; Protein Kinase Inhibitors | 2020 |